Immune-related adverse events associated with the use of immunotherapy in patients with B-cell lymphoblastic leukemia: A protocol for a systematic review and meta-analysis

B-cell acute lymphoblastic leukemia (B-ALL) is a neoplasm of immature B-cells that is more prevalent in children. Despite successful remission rates in patients with B-ALL on chemotherapy, the risk of relapse is high. This has paved way for highly active immune and cell therapies to be intensively e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanovengi, Bianca K., Nkambule, Bongani B., Hauwanga, Edwig, Nyambuya, Tawanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036004/
https://www.ncbi.nlm.nih.gov/pubmed/36961154
http://dx.doi.org/10.1097/MD.0000000000032987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036004/
https://www.ncbi.nlm.nih.gov/pubmed/36961154
http://dx.doi.org/10.1097/MD.0000000000032987

Ejemplares similares